MENU
Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jun 19, 2025

Analysis of Tilray Brands' (TLRY) Stock for June 2025: Market Trends and AI-Powered Perspectives

Tilray Brands, Inc. (Nasdaq: TLRY) is a global leader in the cannabis, beverage, and wellness industries, headquartered in New York and Leamington, Ontario. As a prominent player in the cannabis sector, Tilray has garnered significant investor attention due to its strategic expansions and market performance. This article provides a comprehensive financial analysis of TLRY as of June 19, 2025, incorporating recent market movements, statistical data, comparisons with correlated stocks and inverse ETFs, and the role of AI-driven tools like those offered by Tickeron.com. The analysis also explores how traders can leverage these tools to navigate TLRY’s volatility and optimize their strategies.

TLRY Stock Performance: Recent Trends and Statistics

Tilray Brands has experienced notable volatility in 2025, reflective of the broader cannabis industry and macroeconomic factors. As of June 11, 2025, TLRY closed at $0.42, marking a +2.37% increase from the prior trading day, according to Yahoo Finance. Over the past week, the stock saw a 4.82% price increase, coinciding with the company’s approval of a reverse stock split, which grants greater flexibility in its stock structure. This performance aligns with a positive market environment, as the S&P 500 and Nasdaq recorded gains amid favorable inflation data and U.S.-China trade developments.

Key Financial Metrics

  • Market Capitalization: As of June 2025, Tilray’s market cap stands at approximately $320 million, reflecting its position as a mid-cap stock in the cannabis sector.
  • Price-to-Sales Ratio: TLRY’s price-to-sales ratio is around 0.4x, indicating a potentially undervalued stock relative to its revenue generation.
  • Debt Reduction: In the fiscal quarter ending February 28, 2025, Tilray reduced its total debt by $76 million, achieving a net debt to trailing twelve-month Adjusted EBITDA ratio of less than 1.0x, signaling improved financial health.
  • Trading Volume: Over the five trading days ending June 10, 2025, TLRY’s average daily trading volume was approximately 1.2 million shares, indicating moderate liquidity for a stock in its sector.
  • Year-to-Date Performance: TLRY has faced challenges in 2025, with its stock price down approximately 65% from its January high of $1.20, as noted in posts on X.

Technical Indicators

TLRY’s MACD Histogram crosses above the signal line

The Moving Average Convergence Divergence (MACD) for TLRY turned positive on June 10, 2025. Looking at past instances where TLRY’s MACD turned positive, the stock continued to rise in 38 of 43 cases over the following month. The odds of a continued upward trend are 88%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 62 cases where TLRY’s Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron’s analysis proposes that the odds of a continued upward trend are 87%.

Following a +3.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLRY advanced for three days, in 161 of 198 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

TLRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TLRY as a result. In 68 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for TLRY entered a downward trend on June 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Market News Impacting TLRY: June 19, 2025

The stock market on June 19, 2025, reflects a complex interplay of macroeconomic and geopolitical factors influencing TLRY’s performance. Key market news includes:

  • Geopolitical Tensions: Stocks experienced volatility earlier in the week due to escalating conflicts between Israel and Iran, which pushed energy prices higher and led to a market downturn on June 13. The S&P 500 fell 1.13% to 5,976.97, and the Nasdaq Composite dropped 1.30% to 19,406.83. This broader market decline likely pressured TLRY, given its sensitivity to market sentiment.
  • Federal Reserve Policy: Investors are closely monitoring the Federal Reserve’s two-day meeting, which began on June 17, for indications of interest rate decisions. Expectations of steady rates in 2025, despite cooling inflation, suggest a cautious market environment that could impact high-beta stocks like TLRY.
  • Sector-Specific Developments: The cannabis sector remains under scrutiny due to regulatory uncertainties. However, Tilray’s recent debt reduction and strategic focus on beverage and wellness products position it favorably for long-term growth, even amidst short-term market fluctuations.

Comparison with a Correlated Stock: Canopy Growth Corporation (CGC)

Tilray’s stock performance is closely correlated with other cannabis industry players, notably Canopy Growth Corporation (Nasdaq: CGC). Both companies operate in the global cannabis market and are influenced by similar regulatory and market dynamics. Over the past year, TLRY and CGC have shown a correlation coefficient of approximately 0.85, indicating strong alignment in price movements.

  • Recent Performance: As of June 2025, CGC has also faced significant declines, trading at around $0.65, down 70% year-to-date, mirroring TLRY’s challenges. However, CGC’s larger market cap ($600 million) and broader international presence give it a slightly different risk profile.
  • Key Differences: While Tilray has diversified into beverages and wellness, CGC focuses heavily on cannabis-based pharmaceuticals. This divergence could lead to varied responses to regulatory changes, such as potential U.S. federal legalization, which some X users speculate could drive TLRY to $1.20 or higher.
  • Trading Insights: Investors tracking TLRY and CGC can leverage Tickeron’s AI-driven analytics to compare real-time trends, identifying which stock may offer better upside based on technical indicators like moving average crossovers or relative strength index (RSI).

Leveraging Inverse ETFs for Trading TLRY

For traders seeking to hedge TLRY’s volatility, inverse ETFs like the ProShares Short S&P 500 (SH) offer an anti-correlated instrument. SH aims to deliver the daily inverse performance of the S&P 500, which indirectly anti-correlates with TLRY due to its inclusion in broader market indices. During TLRY’s 4.82% weekly gain in early June 2025, SH likely declined by a similar magnitude, reflecting its inverse relationship.

  • Strategic Advantage: Pairing TLRY with SH allows traders to mitigate losses during market downturns. For instance, if TLRY declines due to sector-specific headwinds, SH’s gains can offset losses, providing a balanced portfolio approach.
  • Risk Considerations: Inverse ETFs like SH are designed for short-term strategies due to daily rebalancing, which can lead to compounding losses in prolonged trends. Tickeron’s AI tools can help traders identify optimal entry and exit points for SH, ensuring precise hedging in TLRY’s volatile trajectory.

Tickeron’s AI Trading Agents: Enhancing TLRY Strategies

Tickeron, led by CEO Sergey Savastiouk, has transformed trading through its Financial Learning Models (FLMs), which integrate machine learning with technical analysis to deliver high-probability trade setups. For TLRY, Tickeron’s AI Trading Robots and Double Agents provide dual-perspective signals, capturing both bullish and bearish trends. For example, Tickeron’s platform identified a bullish moving average crossover for TLRY on May 15, 2025, signaling potential upside to $0.50. By pairing TLRY with inverse ETFs like SH, Tickeron’s Double Agents offer a hedged approach, achieving a +9.77% quarterly gain in a declining market. These tools, accessible at Tickeron’s bot-trading platform, empower traders to navigate TLRY’s volatility with precision, making them essential for both novice and experienced investors.

Conclusion

Tilray Brands (TLRY) remains a compelling yet volatile investment in the cannabis sector as of June 19, 2025. Its recent 4.82% weekly gain, debt reduction, and strategic approval of a reverse stock split signal potential for recovery, despite a challenging year-to-date performance. By comparing TLRY with correlated stocks like CGC and leveraging inverse ETFs like SH, investors can balance risk and reward. Tickeron’s AI-driven tools, with their advanced Financial Learning Models, provide real-time insights and hedging strategies, making them invaluable for navigating TLRY’s market movements. As macroeconomic and regulatory developments unfold, traders should remain vigilant, using platforms like Tickeron.com to stay ahead in this dynamic sector.

Disclaimers and Limitations

Related Ticker: TLRY, CGC

TLRY's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for TLRY turned positive on June 10, 2025. Looking at past instances where TLRY's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TLRY advanced for three days, in of 198 cases, the price rose further within the following month. The odds of a continued upward trend are .

TLRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TLRY as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TLRY entered a downward trend on June 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.545) is normal, around the industry mean (62.463). P/E Ratio (8.518) is within average values for comparable stocks, (89.614). TLRY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (2.355) is also within normal values, averaging (19.198).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TLRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 3.78B. The market cap for tickers in the group ranges from 246 to 77.48B. ZTS holds the highest valuation in this group at 77.48B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 1%. For the same Industry, the average monthly price growth was 16%, and the average quarterly price growth was 254%. RGC experienced the highest price growth at 287%, while CRRTF experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 6%. For the same stocks of the Industry, the average monthly volume growth was 4% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 66
Price Growth Rating: 61
SMR Rating: 83
Profit Risk Rating: 91
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company, whose subsidiaries engages in research, cultivation, processing and distribution of medical cannabis

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
265 Talbot Street West
Phone
+1 844 845-7291
Employees
1600
Web
https://www.tilray.com
Interact to see
Advertisement
Paper wallets are extremely useful tools – beyond being one of the most popular and secure cold storage methods, they make it simple to transfer coins between owners.You can access the funds on your paper wallet by “sweeping” (or importing) them to either a live wallet (like Trezor or Exodus) or an exchange service (like Coinbase). Most services allow you to import them directly from your wallet’s private key, but there are two key exceptions.
Learn the 27 essential intraday trading rules that every manual trader should master—and discover how Tickeron’s AI platform applies them automatically for consistent, emotion-free execution and smarter, real-time decision-making.
#investment#trading
A $2 trillion sell-off has investors asking: is 2025 the next dot-com crash or a replay of the 2008 recession? This deep dive compares both scenarios, outlines warning signs, and reveals how AI-powered trading strategies can help navigate rising volatility.
#trading#investment
New to trading? Discover 21 powerful lessons every beginner must learn—and see how Tickeron’s AI Double Agent strategies apply them in real time. From mastering risk to managing emotions, this guide helps you trade smarter, safer, and more confidently.
#investment#trading
From the railroads of the 1920s to the AI giants of 2025, market history shows that extreme concentration often precedes massive bubbles and crashes. This article explores five key turning points and how Tickeron’s AI helps traders navigate today’s bubble-prone landscape.
#investment#trading
U.S. tariff tensions rocked markets this week, sending tech stocks into retreat and safe-haven assets like gold and the yen soaring. As investors brace for major earnings and global policy shifts, volatility remains high across equities, currencies, and commodities.
#investment#trading
Tesla’s Q1 2025 earnings could surprise investors as the EV giant looks to rebound from last quarter’s miss. With lowered expectations and increased volatility, Tickeron’s AI-powered strategy helps traders navigate both upside potential and downside risk.
#investment#trading
Gold is on a historic run—up 29% YTD with record-breaking inflows and growing macro tailwinds. Discover why smart investors are eyeing gold, silver, and miners for opportunity, and how AI trading tools are unlocking new ways to profit from the 2025 gold rush.
#investment#trading
Tickeron launches its innovative Double Agent Trading Bot, combining long NVDA trades with hedged NVDS positions. Using AI-driven pattern trading and real-time risk management, the bot achieves a 75% success rate, revolutionizing automated trading strategies.
#trading#investment
Tickeron’s AI trading bots are setting new standards in finance, achieving up to 86.6% win rates across leveraged and sector ETFs. Powered by advanced Financial Learning Models (FLMs), Tickeron’s AI delivers precision, adaptability, and real-time trading success.
#trading
Wall Street expects strong profit growth from the Magnificent Seven tech giants in 2025. Discover how to trade Apple, Microsoft, Amazon, Nvidia, Tesla, Meta, and Alphabet using AI-powered Double Agent strategies and smart hedging with inverse ETFs like QID.
On May 2, 2025, a diverse group of companies across energy, financial services, basic materials, consumer discretionary, and healthcare will release their Q1 2025 earnings.
In April 2025, five tech giants—NVIDIA, Tesla, Meta, Palantir, and Amazon—each surged over 40%, driven by AI breakthroughs, strong earnings, and market momentum. Discover what fueled the rally and how Tickeron’s AI trading bots helped investors outperform even these star stocks.
#investment
Markets ended April with mixed signals—gold slid on trade optimism, Big Tech lifted the Nasdaq, and Bitcoin steadied near $94K. With U.S. GDP contracting and job growth beating forecasts, investors brace for more volatility amid tariffs and central bank moves.
In a turbulent market, Tickeron's AI-powered Double Agent Bot is outperforming traditional strategies. Leveraging real-time intraday signals and inverse ETFs, the bot posted a +9.77% quarterly gain while the S&P 500 dropped 9.28%. Here's how AI is reshaping trading.
#trading
As Warren Buffett announces his retirement, investors turn to his trusted Buffett Indicator—a ratio of market cap to GDP—as a key gauge of market valuation.
#investment
Markets move in repeating cycles—Accumulation, Uptrend, Distribution, and Downtrend. Learn how to recognize each phase and deploy Tickeron’s AI-powered Double Agent strategy to adapt, protect capital, and profit in any market condition.
#trading
Discover how confirmation trading techniques—like moving average crossovers and volume-backed breakouts—can improve accuracy and reduce false signals. Learn how Tickeron’s AI automates these strategies for smarter, faster, and more disciplined trading.
#trading
Hedge funds are ramping up bearish bets on small-cap stocks, with Russell 2000 short interest hitting new highs. As macro headwinds mount and technical support teeters, Tickeron’s AI Double Agents step in to navigate the looming sell-off with precision.
#investment#trading#artificial_intelligence
SPY’s Momentum Indicator turned bullish on April 25, 2025, signaling a potential trend shift with a 90% historical success rate. This article explores how economic scarcity, technical signals, and AI-driven tools like Tickeron’s A.I.dvisor shape investor decisions in volatile markets.
#trading